期刊文献+

CD44s、CD44v6在颅内转移瘤与胶质母细胞瘤中的表达研究

Expression and its implication of CD44s and CD44v6 in human brain metastases and glioblastomas
下载PDF
导出
摘要 目的:探讨粘附分子CD44基因蛋白在颅内转移瘤及胶质母细胞瘤中的表达及其与这些肿瘤侵袭、转移之间的关系。方法:应用标准型CD44(CD44s)和变异型CD44v6基因蛋白单克隆抗体,微波-LSAB免疫组化染色检测20例正常脑组织、35例脑胶质母细胞瘤和30例颅内转移瘤中CD44基因蛋白的表达情况。结果:20例正常脑组织中CD44s和CD44v6表达均为阴性:35例脑胶质母细胞瘤CD44s阳性表达率为100%(35/35),CD44v6表达为阴性:30例颅内转移瘤中CD44s阳性表达率为86.7%(26/30),CD44v6阳性表达率为66.7%(20/30)。CD44v6在颅内转移瘤及脑胶质母细胞瘤的表达差异有显著性(P<0.01)。结论:脑胶质母细胞瘤中CD44S的表达可能与其脑内侵袭过程有关,无CD44v6表达可能与其很少发生颅外转移有关,并有可能成为颅内转移瘤诊治的有用指标之一。 Objective: To investigate the expression of CD44 genes protein in human brain metastases and human glio blastomas. and the relationship between the expression of CD44 adhesion molecules and the invasion or metastasis of these tumors. Methords: Monoclonal antibody to standard CD44(CD44s) and polyclonal antibody to variant CD44(CD44v6) were used to detect the expression of CD44 adhesion molecules in 20 normal human brain tissues,35 human glioblastomas, ancl 30 brain metastases by microwave immunohistochemical staining technique. Results: The expression of CD44s and CD4v620 were negative in normal brain tissues. All 35 glioblastomas and 86. 7% (26/30) brain metastases expressed CD44s. No glioblastomas and 66. 7% (20/30) brain metastases expressed CD44v6 with a significant difference(P<0. 01). Conclusion: CD44s may play an important role in the invasion of glioblastomas and biological signficance of lack of CD44v6 expression in human glioblastomas may be responsible for their inability to metastasize extraneurally. CD44v6 expression may be a useful marker for diagnosis and treatment of patients with brain metastases.
出处 《脑与神经疾病杂志》 2004年第6期435-436,共2页 Journal of Brain and Nervous Diseases
关键词 CD44基因蛋白 胶质母细胞瘤 颅内转移瘤 免疫组织化学 CD44 genes protein Brain metastases Glioblastoma Immunohistochemistry
  • 相关文献

参考文献13

  • 1熊正文.免疫组织化学技术中抗原修复的研究进展[J].中华病理学杂志,1997,26(2):124-126. 被引量:74
  • 2熊正文,李春光,丁华野,史景泉,田玉旺.增强免疫细胞化学染色敏感性的新技术研究及应用[J].诊断病理学杂志,2000,7(2):147-149. 被引量:20
  • 3Fukuse T, Hirata T, Naiki H, et al.Expression of proliferating cell nuclear antigen and cd44 variant isoforms in the primary and metastatic sites of nonsmall cell lung carcinoma with intrapulmonary metastases,Cancer. 1999,86:1174
  • 4Iida N,Bourguignon LYW,New CD44 splice variants associated with human breast cancers J Cell Physiol, 1995; 102:127
  • 5Russell DS,Rubinstein LJ.Pathology of Tumors of the Nervous System. London:Edward Amold, 1989.437
  • 6Herrlich P,Zoller M,Pals ST et al. CD44 splice variants:metastases meet lymphocytes, Immunol Today 1993; 14:395
  • 7Guo YJ, Liu CT,Wang X,et al.Potential use of soluble CD44 in serum as indicator of burden and metastasis in patients with gastric or colon cancer. Cancer Res, 1994,54:422
  • 8Salmi M, Gron VK,Sonitu P et al, Regulated expression of exon V6 containing isoforms of CD44 in man downregula-tion during malignant transformation of tumors of squamo- cellular origin J Cell Biol, 1993; 122:431
  • 9Gunthert U, APC M, Hofmann M, Rudy W,et al.A new variant of glycoprotein CD44 confers metastatic potential to rat carcinoma cells. Cell. 1991,65:13
  • 10Naot D,Sionov RV,Schalom DI.CD44:structure/function/and association with malignant process.Adv Cancer Res, 1997,71:241

二级参考文献25

  • 1熊正文.免疫组织化学技术中抗原修复的研究进展[J].中华病理学杂志,1997,26(2):124-126. 被引量:74
  • 2熊正文,中国组织化学与细胞化学杂志,1996年,5卷,71页
  • 3熊正文,解剖学杂志,1995年,8卷,289页
  • 4Shi S R,Biotech-Histochem,1994年,69卷,213页
  • 5熊正文,中国组织化学与细胞化学杂志,1994年,3卷,407页
  • 6蔡文琴,实用免疫细胞化学与核酸分子杂交技术,1994年,1页
  • 7熊正文,北京军区医药,1993年,5卷,461页
  • 8Shi S R,J Histochem Cytochem,1991年,39卷,741页
  • 9陈钦材,病理学进展.1,1987年,16页
  • 10Iida N,Bourguignon LYW,New CD44 splice variants asso ciated with human breast cancers.Cell Physiol,1995,102:127

共引文献101

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部